Consistent with these findings, a similar conclusion has been drawn for cervical squamous cell carcinoma (CECC) [107], revealing that patients with PIK3CA-E545K presented only a partial response to treatment with PD-1 inhibitors. Here, PIK3CA is linked to cervical squamous cell carcinoma.